Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-09-06
2005-09-06
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S423000
Reexamination Certificate
active
06939863
ABSTRACT:
The present application concerns pharmaceutical compositions, methods of use thereof and medical devices for preventing or treating atherosclerosiss or restenosis or both. The present invention discloses a pharmaceutical composition, including a pharmaceutically acceptable carrier and PTU in an amount sufficient to prevent atherosclerosis or restenosis in a subject. The present invention further discloses a method of inhibiting atherosclerosis or restenosis in a subject, including identifying a subject suspected of needing inhibition of atherosclerosis or restenosis and administering to the subject PTU in an amount sufficient to prevent atherosclerosis or restenosis in the subject. The present invention further discloses an article of manufacture including a medical device and PTU.
REFERENCES:
patent: 5310742 (1994-05-01), Elias et al.
patent: 5571523 (1996-11-01), Lee et al.
patent: 5773029 (1998-06-01), Chiesi et al.
patent: 5821260 (1998-10-01), Medford et al.
patent: 6096753 (2000-08-01), Spohr et al.
patent: 6365616 (2002-04-01), Kohn et al.
patent: 2002/0022022 (2002-02-01), Shi et al.
patent: 2002/0025979 (2002-02-01), Kunz et al.
patent: 96/28114 (1996-09-01), None
patent: WO 96/28114 (1996-09-01), None
patent: 00/10980 (2000-03-01), None
patent: 01/60805 (2001-08-01), None
Bennett et al., “Vascular Smooth Muscle Cell Apoptosis—A Dangerous Phenomenon in Vascular Disease?”, Journal of Clinica and Basic Cardiology, vol. 3, issue 1, 2000, pp. 63-65.
Lee et al., Exp. Cell. Res. 239(2):447-453 (1998), Synchronization of cultured vascular smooth muscle cells following reversal of quiescence induced by treatment with the antioxidanyt N-acetylcysteine.
Tsai et al., J. Biol. Chem., 271:3667-3670 (1996). Induction of apoptosis by pyrrolidiniedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells.
Ialenti et al., Naunyn Schmiedeberg's Arch. Pharmacol., 364(4):343-350 (2001), Role of nuclear factor-kB in a rat model of vascular injury.
Cao et al., Biochem. Biophys. Res. Comm., 292(1):50-57 (2002), Chemical induction of cellular antioxidants affords marked protection against oxidative injury in vascular smooth muscle cells.
Hicks et al., Biochem, Pharmacol., 43(3):439-444 (1992), Antioxidant activity of proplthiouracil.
Faure et al., Chem. Biol. Interact., 77:173-185 (1991), Evaluation of the antioxidant properties of thyroid hormones and propylthiouracil in the brain-homogenate autoxidation system and in the free radical-mediated oxidation of erythrocyte membranes.
Grieve et al., Brit. J. Pharmacol., 127(1):1-8 (1999), Effects of oral propylthiouracil treatment on nitric oxide production in rat aorta.
Adali et al., Clin. Biochem., 32(5):363-367 (1999), Effects of propylthiouracil, propranolo, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients.
Giuriato et al., Arteriscler. Thromb., 11(5):1376-89 (1991), Aortic intimal thickening and myosin isoform expression in hyperthyroid rabbits.
Finking et al., Atherosclerosis, 135:1-7 (1997), Nikolaj Nikolajewitsch Anitshcokow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research.
Johnson et al., Thromb. Haemost., 81:835-843 (1999), Scientific and Standardization Committee Communication. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular, and Molecular Models of Throbosis and Haimostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Narayanaswamy et al., J. Vasc. Interv. Radiol., 11:5-17 (2000), State of the art: Animal models for atherosclerosis, restenosis, and endovascular graft research.
Ross et al. J Pharmacol Exp Therapeutics 285:1233-1238 (1998), Effect of Antithyroid Drugs on Hdroxyl Radical Formation and α-1-Proteinase Inhibitor Inactivation by Neutrophils: Therapeutic Implications.
Ferns et al. Proc Natl Acad Sci, 89:11312-11316 (1992), Probucol inhibits neointimal thckening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit.
Freyschuss et al, J Clin Invest 91:1282 (1993), Antioxidant Treatment Inhibits the Development of Intimal Thickening after Balloon Injury of the Aorta in Hypercholesterolemic Rabbits.
Konneh et al, Atherosclerosis 113:29-39 (1995), Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat.
Ross, N Engl J Med 340:115-126 (1999), Atherosclerosis—An Inflammatory Disease.
Serruys et al, N Engl J Med 331:489-495 (1994) A Comparison of Balloon-Expandable-Stent Implantation With Balloon Angioplasty In Patients With Coronary Artery Disease.
Post et al, Circulation 89:2816-2821 (1994) The Relative Importance Of Aterial Remodeling Compared With Intimal Hyperplasia In Lumen Renarrowing After Balloon Angioplasty.
Painter et al. 75:398-400 (1995), Serial Intravascular Ultrasound Studies Fail to Show Evidence of Chronic Palmaz-Schatz Stent Recoil.
Honda et al, Circulation 104:380-383 (2001), Inravascular Ultrasound Observations From the First Human Experience With the QP2-Eluting Polymer Stent System.
David R Preston & Associates
McIntosh III Traviss C.
Preston David
Wilson James O.
LandOfFree
Prevention of atherosclerosis and restenosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of atherosclerosis and restenosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of atherosclerosis and restenosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3417998